First Time Loading...

Camurus AB
STO:CAMX

Watchlist Manager
Camurus AB Logo
Camurus AB
STO:CAMX
Watchlist
Price: 482.8 SEK -2.86%
Updated: May 7, 2024

Intrinsic Value

Camurus AB operates as a research based pharmaceutical company. [ Read More ]

The intrinsic value of one CAMX stock under the Base Case scenario is 841.51 SEK. Compared to the current market price of 482.8 SEK, Camurus AB is Undervalued by 43%.

Key Points:
CAMX Intrinsic Value
Base Case
841.51 SEK
Undervaluation 43%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Camurus AB

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling CAMX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Camurus AB

Provide an overview of the primary business activities
of Camurus AB.

What unique competitive advantages
does Camurus AB hold over its rivals?

What risks and challenges
does Camurus AB face in the near future?

Summarize the latest earnings call
of Camurus AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Camurus AB.

Provide P/S
for Camurus AB.

Provide P/E
for Camurus AB.

Provide P/OCF
for Camurus AB.

Provide P/FCFE
for Camurus AB.

Provide P/B
for Camurus AB.

Provide EV/S
for Camurus AB.

Provide EV/GP
for Camurus AB.

Provide EV/EBITDA
for Camurus AB.

Provide EV/EBIT
for Camurus AB.

Provide EV/OCF
for Camurus AB.

Provide EV/FCFF
for Camurus AB.

Provide EV/IC
for Camurus AB.

Show me price targets
for Camurus AB made by professional analysts.

What are the Revenue projections
for Camurus AB?

How accurate were the past Revenue estimates
for Camurus AB?

What are the Net Income projections
for Camurus AB?

How accurate were the past Net Income estimates
for Camurus AB?

What are the EPS projections
for Camurus AB?

How accurate were the past EPS estimates
for Camurus AB?

What are the EBIT projections
for Camurus AB?

How accurate were the past EBIT estimates
for Camurus AB?

Compare the revenue forecasts
for Camurus AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Camurus AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Camurus AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Camurus AB compared to its peers.

Compare the P/E ratios
of Camurus AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Camurus AB with its peers.

Analyze the financial leverage
of Camurus AB compared to its main competitors.

Show all profitability ratios
for Camurus AB.

Provide ROE
for Camurus AB.

Provide ROA
for Camurus AB.

Provide ROIC
for Camurus AB.

Provide ROCE
for Camurus AB.

Provide Gross Margin
for Camurus AB.

Provide Operating Margin
for Camurus AB.

Provide Net Margin
for Camurus AB.

Provide FCF Margin
for Camurus AB.

Show all solvency ratios
for Camurus AB.

Provide D/E Ratio
for Camurus AB.

Provide D/A Ratio
for Camurus AB.

Provide Interest Coverage Ratio
for Camurus AB.

Provide Altman Z-Score Ratio
for Camurus AB.

Provide Quick Ratio
for Camurus AB.

Provide Current Ratio
for Camurus AB.

Provide Cash Ratio
for Camurus AB.

What is the historical Revenue growth
over the last 5 years for Camurus AB?

What is the historical Net Income growth
over the last 5 years for Camurus AB?

What is the current Free Cash Flow
of Camurus AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Camurus AB.

Financials

Balance Sheet Decomposition
Camurus AB

Current Assets 1.6B
Cash & Short-Term Investments 1.2B
Receivables 300.8m
Other Current Assets 133.5m
Non-Current Assets 283.8m
PP&E 39.7m
Intangibles 22.7m
Other Non-Current Assets 221.3m
Current Liabilities 368.6m
Accounts Payable 99.3m
Accrued Liabilities 213.7m
Other Current Liabilities 55.6m
Non-Current Liabilities 46.2m
Long-Term Debt 13.6m
Other Non-Current Liabilities 32.6m
Efficiency

Earnings Waterfall
Camurus AB

Revenue
1.7B SEK
Cost of Revenue
-122.3m SEK
Gross Profit
1.6B SEK
Operating Expenses
-1.1B SEK
Operating Income
533.4m SEK
Other Expenses
-102m SEK
Net Income
431.4m SEK

Free Cash Flow Analysis
Camurus AB

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

CAMX Profitability Score
Profitability Due Diligence

Camurus AB's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional ROIC
Exceptional Revenue Growth Forecast
59/100
Profitability
Score

Camurus AB's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

CAMX Solvency Score
Solvency Due Diligence

Camurus AB's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Camurus AB's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CAMX Price Targets Summary
Camurus AB

Wall Street analysts forecast CAMX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CAMX is 570.69 SEK with a low forecast of 449.45 SEK and a high forecast of 724.5 SEK.

Lowest
Price Target
449.45 SEK
7% Downside
Average
Price Target
570.69 SEK
18% Upside
Highest
Price Target
724.5 SEK
50% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

CAMX Price
Camurus AB

1M 1M
-6%
6M 6M
+37%
1Y 1Y
+95%
3Y 3Y
+138%
5Y 5Y
+590%
10Y 10Y
+699%
Annual Price Range
482.8
52w Low
247.8
52w High
595
Price Metrics
Average Annual Return 48.02%
Standard Deviation of Annual Returns 60.17%
Max Drawdown -44%
Shares Statistics
Market Capitalization 26.9B SEK
Shares Outstanding 57 623 600
Percentage of Shares Shorted
N/A

CAMX Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Camurus AB Logo
Camurus AB

Country

Sweden

Industry

Pharmaceuticals

Market Cap

26.9B SEK

Dividend Yield

0%

Description

Camurus AB operates as a research based pharmaceutical company. The company is headquartered in Lund, Skane and currently employs 148 full-time employees. The company went IPO on 2015-12-03. The firm has a diversified research portfolio, which includes five products in clinical trials, and a number of additional product candidates in the pre-clinical phase. The Company’s product pipeline represents a mix of in-house and partnered projects in different development phases. Camurus AB is the parent company of the Group, which comprises four legal entities, namely Camurus Inc, Cubosome Inc, Camurus Development AB and Bioimplant Scandinavia AB.

Contact

SKANE
Lund
Ideon Science Park.
+46462865730.0
https://www.camurus.com/

IPO

2015-12-03

Employees

148

Officers

President, CEO, CSO & Director
Mr. Fredrik Tiberg
Chief Financial Officer
Mr. Jon U. Garay Alonso
Chief Technology Officer
Mr. Torsten Malmstrom
Vice President of Investor Relations
Mr. Rein Piir B.Sc.
Global Head of Human Resources
Ms. Maria Lundqvist
Senior Vice President of R&D
Mr. Markus Johnsson
Show More
Chief Business Development Officer
Mr. Fredrik Joabsson
Chief Commercial Officer
Mr. Richard Jameson
Chief Medical Officer
Mr. Alberto M. Pedroncelli
Show Less

See Also

Discover More
What is the Intrinsic Value of one CAMX stock?

The intrinsic value of one CAMX stock under the Base Case scenario is 841.51 SEK.

Is CAMX stock undervalued or overvalued?

Compared to the current market price of 482.8 SEK, Camurus AB is Undervalued by 43%.